Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada flag Canada · Delayed Price · Currency is CAD
0.1000
-0.0050 (-4.76%)
Sep 18, 2026, 12:37 PM EST

Rapid Dose Therapeutics Revenue

Rapid Dose Therapeutics had revenue of 584.52K CAD in the quarter ending May 31, 2026, a decrease of -25.32%. This brings the company's revenue in the last twelve months to 2.58M, up 4.30% year-over-year. In the fiscal year ending February 28, 2026, Rapid Dose Therapeutics had annual revenue of 2.77M with 33.00% growth.

Revenue (ttm)
2.58M
Revenue Growth
+4.30%
P/S Ratio
5.30
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.64M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Feb 28, 20262.77M688.14K33.00%
Feb 28, 20252.09M1.06M104.34%
Feb 29, 20241.02M302.13K42.06%
Feb 28, 2023718.30K-1.03M-59.00%
Feb 28, 20221.75M996.72K131.98%
Feb 28, 2021 Pro Pro Pro
Feb 29, 2020 Pro Pro Pro
Feb 28, 2019 Pro Pro Pro
Feb 28, 2018 Pro Pro Pro